RGH-896 WITH NEUROPATHIC PAIN DUE TO SPINAL CORD INJURY

RGH-896 因脊髓损伤引起神经性疼痛

• 批准号: 7607382
• 负责人: CHRISTINE NAI-MEI SANG
• 金额: $ 0.06万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607382
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Dose; Funding; Grant; Institution; Oral; Placebos; Purpose; Research; Research Personnel; Resources; Source; Spinal cord injury; United States National Institutes of Health; Week; painful neuropathy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to assess the efficiency of a well-tolerated oral dose of RGH-896 compared with that of placebo administered for 4 weeks in reducing neuropathic pain associated with spinal cord injury. This is an investigator-initiated study.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究的目的是评估口服良好的RGH-896口服剂量的效率，而在减少与脊髓损伤相关的神经性疼痛中施用了4周的安慰剂。 这是一项研究人员发起的研究。